Antiviral efficacy of CPC against SARS-CoV-2 in cell cultures expressing TMPRSS2 (IMAGE)

Hokkaido University

Antiviral efficacy of CPC against SARS-CoV-2 in cell cultures expressing TMPRSS2

Caption

Antiviral efficacy of CPC against SARS-CoV-2 in cell cultures expressing TMPRSS2. For all of the four strains tested, a concentration of 40 µg/mL of CPC significantly reduced the viral titers, the number of virus particles. Asterisks indicate significant results (Ryo Takeda, et al. Scientific Reports. August 18, 2022).

Credit

Ryo Takeda, et al. Scientific Reports. August 18, 2022

Usage Restrictions

This image is copyrighted but may be used to report this press release if credited as instructed.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.